Contact-free market shopping has come to campus at UH. Photo courtesy of UH

A convenience store on campus at the University of Houston just got a little more, well, convenient — and a whole lot safer.

UH and its dining services partner, Chartwells HigherEducation, have partnered with tech company Standard to upgrade the check-out process of convenience shopping. The technology is easy to install and can retrofit any convenience store to a contact-less process.

"Students' tastes change constantly, and we're well equipped to handle that. But their shopping preferences evolve too, and we want to continue providing new and unique shopping experiences that are unexpected on a college campus," says David Riddle, vice president of operations for Chartwells Higher Ed, and district manager for UH System Dining, in a press release. "This is the future of shopping, and with autonomous checkout through Standard, we've made it as easy, safe and convenient as possible for students to come in, get what they need, and go."

The store, called Market Next, is located at UH's Technology Bridge and opened earlier this month. Enabled by cameras and easy-to-use scanners, the store operates 24 hours a day and is also designed for quick service for students on the go. The fastest shopping trip recorded by Standard is 2.3 seconds.

"Market Next is the first retail store in the world to be retrofitted for a 100 percent cashierless, checkout-free experience," says Jordan Fisher, co-founder and CEO of Standard, in the release. "Our platform is the only system on the market proven to retrofit an entire retail experience. Innovative retailers like Chartwells use the AI-powered Standard platform to enable shoppers to grab any product they want and simply walk out, without waiting in line. We are excited to partner with Chartwells to deliver this groundbreaking technology to more locations around the country."

Chartwells is working with Standard to bring more of these stores across the country — as well as more itterations on the UH campus.

"Checkout-free technology is an innovation that will make our students' lives a little easier and a lot safer. This is the new standard for campus safety that is important to students today and for the foreseeable future," says Emily Messa, associate vice chancellor and associate vice president for administration at UH, in the release. "That's why we will plan to convert additional Market stores on campus to this technology in the coming year."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.